Efficacy and Cardiovascular Tolerability of Minotricon in the Treatment of Seborrheic Alopecia

    October 1990 in “ PubMed ”
    C. Rigoni, Sara Pinelli, P Toffolo … C Terenzio
    Studysummary This study evaluated local treatment with minoxidil 2% watery solution in patients with androgenetic alopecia but did not report detailed clinical outcomes.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pubmed.ncbi.nlm.nih.gov →
    Discuss this study in the Community →

    Related research 8

    1. Systemic Minoxidil for Hair Disorders in Pediatric Patients: A Safety and Tolerability Review International Journal of Dermatology · 2022
    2. Role of Low Dose Oral Minoxidil in the Treatment of Hair Loss: A Review Cosmoderma · 2021
    3. Adverse Effects of Low-Dose Oral Minoxidil for Androgenetic Alopecia in 435 Patients Journal of The American Academy of Dermatology · 2020
    4. Pustular Dermatosis of the Scalp Due to Topical Minoxidil 5% 2018
    5. Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata Archives of Dermatology · 1992
    6. Efficacy and Cardiovascular Tolerability of Minotricon in the Treatment of Seborrheic Alopecia PubMed · 1990
    7. Topical Minoxidil in Extensive Alopecia Areata, Including 3-Year Follow-Up Dermatology · 1987
    8. Alopecia Areata Treated With Topical Minoxidil Archives of Dermatology · 1984